Aeva Technologies heads into this week with a striking contrast: one of the most heavily shorted small-cap names in the sensor space, yet options traders are the least bearish they have been all year.
The short position is deep and sticky. Short interest accounts for roughly 27.7% of Aeva's free float — a level that has barely budged over the past six weeks, oscillating in a narrow 27.2%–28.1% band since late March. The FINRA-reported figure of 8.4 million shares and a days-to-cover of 8.4 reinforce the picture: this is a structural bear thesis, not a reactive short. At the same time, borrow availability has tightened meaningfully, with the lending pool now about 82% utilised — well off the 52-week peak of 94% hit in late March but high enough to constrain new short-building. Cost to borrow, at just under 1%, remains negligible. That means the short side isn't under financial pressure from carry costs, but fresh supply of shares to borrow is growing thin.
Options positioning flatly contradicts the short story. The put/call ratio has drifted down to 0.196 — essentially at its 52-week low of 0.191 and almost a full standard deviation below its 20-day average of 0.213. This is the most call-heavy options skew Aeva has seen in a year. The sharp drop in the PCR from the 0.23–0.24 range seen in mid-April suggests a pivot: traders who had been buying modest downside protection through April appear to have rotated into calls, possibly positioning around the Q1 earnings release that appears to have fallen on May 6.
The analyst community has been quiet in 2026 — no confirmed target changes have come through since February. The most recent available data shows a mean price target of $24.10 against a current price of $15.24, implying roughly 58% nominal upside. Coverage is skewed bullish: Oppenheimer and Roth Capital have maintained Outperform and Buy ratings, while Morgan Stanley sits at Equal-Weight. The bull case centres on Aeva's FMCW LiDAR architecture as a differentiated platform, the Daimler Trucks commercial win, and long-run passenger OEM revenue that forecasters project scaling dramatically through the early 2030s. Bears point to the LiDAR sector's persistent commercialisation delays, the collapse of rival Luminar's Volvo partnership, and Aeva's pre-revenue operating profile as reasons for caution on the timeline.
Insider activity reinforces some of that caution. The founders and CFO ran coordinated selling programmes at the start of January, with CEO Soroush Salehian Dardashti disposing of roughly 553,000 shares across two days at prices between $12.95 and $18.85. CFO Saurabh Sinha added a further 60,000 shares sold across January and early March. Net insider activity over the 90-day window to early March amounts to just over 1 million shares sold for approximately $15 million in proceeds. The selling happened into a rising price, which provides some context, but the uniformity of direction across founders and management is hard to dismiss as routine diversification.
On the institutional side, BlackRock added roughly 496,000 shares in its most recent filing through April 30, lifting its stake to 4.3% of the company. Vanguard and Geode also added modestly. Meanwhile, co-founder and Chairman Mina Rezk trimmed by 489,000 shares as of March 17, cutting his personal holding to 4.2%. The largest single holder, Sylebra Capital, reported no change at 25.8% as of December 31 — its next filing will be the cleaner read on whether that conviction has been maintained.
The next scheduled catalyst is a Q2 earnings call on June 18. With a structurally large short position that has not meaningfully covered despite a 15% stock gain over the past month, a call-heavy options market running close to a one-year extreme, and a management team that sold aggressively earlier in the year, the gap between how options traders and short sellers are positioned is the dynamic worth watching most closely into the summer.
See the live data behind this article on ORTEX.
Open AEVA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
